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To realize the promise of stem cell biology, it is
important to identify the precise time in the history
of the cell when developmental potential is re-
stricted. To achieve this goal, we developed a real-
time imaging system that captures the transitions in
fate, generating neurons, astrocytes, and oligoden-
drocytes from single CNS stem cells in vitro. In the
presence of bFGF, tripotent cells normally produce
specified progenitors through a bipotent intermedi-
ate cell type. Surprisingly, the tripotent state is reset
at each passage. The cytokine CNTF is thought to
instruct multipotent cells to an astrocytic fate. We
demonstrate that CNTF both directs astrogliogene-
sis from tripotent cells, bypassing two of the three
normal bipotent intermediates, and later promotes
the expansion of specified astrocytic progenitors.
These results show how discrete cell types emerge
from a multipotent cell and provide a strong basis
for future studies to determine the molecular basis
of fate specification.
INTRODUCTION
In spite of the great interest in the developmental potential of
mammalian stem cells, there are very few studies where the pre-
cise logic and timing of fate choice has been defined. The pres-
ence of hematopoietic stem cells (HSCs) was first suggested by
the ability of stem cells to form clonal colonies in the spleen and
to reconstitute the murine hematopoietic system (Till et al.,
1964). Immunosorting and functional reconstitution supports
a developmental hierarchy in which stem cells generate terminal
fates through discrete intermediate progenitors (Osawa et al.,
1996; Spangrude et al., 1988; Weissman, 1994). However,
many fundamental aspects of how HSCs generate terminal fates
are still unresolved. These include the relative importance of
intrinsic and extrinsic factors and the precise timing of the events
in the commitment of HSCs to different fates (Ogawa, 1993).670 Cell Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier IncA complete stem cell lineage remains to be determined for the
hematopoietic system or any other mammalian tissue. In vitro
cultures of telencephalic cortical neural stem cells give rise to
neurons, astrocytes, and oligodendrocytes (Davis and Temple,
1994; Johe et al., 1996). Maintenance of the undifferentiated
stem/progenitor cell is a significant unresolved issue in develop-
mental biology and medicine. Lineage analysis of cells from the
developing mouse telencephalon suggests that a cell-intrinsic
asymmetric process regulates self-renewal and the production
of discrete neuronal classes (Qian et al., 2000; Shen et al., 2006).
The lineage path from a single neural stem/progenitor cell to
the production of neurons, astrocytes, and oligodendrocytes
has never been established. The aim of this work is to define
the discrete steps in producing a complex cell population from
a single cultured cell. The technical challenges of long-term im-
aging in vivo prohibit the acquisition of complete lineages. The
advantage of working on in vitro cultured samples is that direct
access to each cell in a lineage may be possible. Further, the
wide use of cultured CNS stem cells in research requires the ac-
curate definition of changes in cell state through time. Most cell-
based therapeutic applications will require expansion of primary
cells in culture before grafting. For these reasons, it is critical to
define the progression in cell state for cultured primary neural
stem cells.
We developed an in vitro system that allows analysis of the
transitions in fate from multipotent CNS stem cells to differenti-
ated neurons and glia. The system includes a novel live-cell
chamber, a method to restrict migration to the visual field and
a methodology to determine the points of fate specification. In
this work, we refer to cells that produce only one cell type as
specified rather than committed (Slack, 1991).
We find that multipotent precursor (stem) cells are normally
specified into discrete fates through the three possible bipotent
intermediates that give rise to neurons+astrocytes (NA), neuro-
ns+oligodendrocytes (NO), and astrocytes+oligodendrocytes
(AO). Using CNTF, a ligand widely used to produce astrocytes
from neural stem cells, we show that instructive and selective ef-
fects regulate discrete intermediate cell types in astrogliogene-
sis. CNTF instructs tripotent cells to the astrocytic fate directly,
bypassing the NA and AO bipotent intermediates, and later,
CNTF promotes selective expansion of astrocytic precursors.
These results demonstrate that through complete lineage.
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The response of multipotent cells to environmental variables in-
dicates that the mechanisms that specify distinct fates within the
same cell are differentially sensitive.
RESULTS
Lineage Analysis
To obtain control cell lineages, we followed the development of
neurons, astrocytes, and oligodendrocytes from single primary
neural stem/progenitor cells derived from the embryonic day
14.5 (E14.5) rat telencephalon using time-lapse imaging. The ra-
tionale for developing a system around the E14.5 rat telenceph-
alon is that significant numbers of neurons, astrocytes, and oli-
godendrocytes can be derived from single cells in clonal
assays from this developmental stage (Johe et al., 1996). In the
few previous studies that derive functional neurons from CNS
stem cells, most required an astrocytic support cell (Blondel
et al., 2000; Song et al., 2002; Vicario-Abejon et al., 1998). For
the production of functional neurons, we used a strategy where
CNS stem cells were plated and expanded in DMEM/F12 with
the N2 supplement (hereafter referred to as N2) in the presence
of bFGF for 3 days. Cell-cycle withdrawal was initiated by remov-
ing bFGF and culturing cells for 2 days in the absence of bFGF.
Neuronal maturation was stimulated by growing cells for 3 days
in Neurobasal media with the B-27 supplement, neurotrophin 3
(NT3), and brain-derived neurotrophic factor (BDNF). Using volt-
age-clamp recording (Supplemental Experimental Procedures),
we showed that this condition promotes excitable currents in
87% of the cells with neuronal morphology without the need
for exogenous astrocytes or serum (Figure S1 and Table S1).
These conditions that support functional neuronal differentiation
are used as control conditions throughout this work.
To image the specification of progenitor cell types, we devel-
oped a culture chamber that controls media and gas exchange
over the microscope stage, emulating the environment in a tis-
sue-culture incubator (Figure S2 and Supplemental Experimen-
tal Procedures; U.S. Patent Number 7,091,035). Imaging every
2 minutes with a 403 oil immersion objective gave sufficient
time and space resolution for complete lineage analysis. In total,
this work is based upon the complete lineages from 326 founder
cells. Manual tracking of these founders produced lineages for
a total of 7269 cells after expansion and differentiation.
Fate Specification Occurs Early
Figure 1A shows single frames taken from 4,860 images (Movie
S1). The low frequency of cell loss due to migration out of the visual
field was achieved by restricted growth areas (Figure S3; U.S. Pat-
ent Number 7,276,367). Epifluorescence from conjugated fibro-
nectin shows this area in the first panel that is outlined at day 4.
This area contains 4 cells at the beginning of the recording (12 hr
after plating) and 43 cells 7 days later when cell identity was estab-
lished using immunoreactivity and morphology (last panel in
Figure 1A). Cells with unambiguous oligodendrocytic morphology
that die before fixation are labeled as oligodendrocytes. The line-
age dendrogram in Figure 1B is derived from analysis of Movie S1.
By marking the terminal leaves on the lineage tree with colors
that represent discrete fates, one observes a clustering of com-
mon fate among closely related cells (Figure 1B). The observationCethat terminal cells derived from a common ancestor share the
same fate could reflect early specification of the ancestor or a ran-
dom series of coincident events. To address these competing hy-
potheses, we developed a statistical hypothesis testing proce-
dure that uses terminal cell fates and mitosis times to calculate
the probability that the distribution of same-fate siblings is ran-
dom or nonrandom throughout the entire period of culture. Apply-
ing this test to the last time point in the experiment, we found that
the occurrence of same-fate siblings is not random. Testing ear-
lier time points, we identified the time at which the average prob-
ability of same-fate siblings becomes nonrandom (p > 0.05). This
point is marked with an asterisk in Figure 1B (see Supplemental
Experimental Procedures for details). This early specification of
fate was validated by multiple approaches described below.
Based on this statistical evidence, we retrospectively labeled
cells as specified if they give rise to only one cell type. Parent cells
are labeled with the fate of their daughters if both daughter cells
share the same fate (Figure 1C). If siblings do not share the
same fate, then the parent cell is labeled as unspecified. Lost
and unstained cells are treated as alternative known fates. If
two siblings die, then the parent is specified as a dying cell. How-
ever, if a single daughter cell dies, then the parent is specified
by the fate of the surviving daughter. This decision is justified
because the majority of dying cells in control lineages occur in
later generations when sibling cells normally share the same fate
(shown later in Figure 4A). Figure 1D is derived from Figure 1B
using retrospective annotation. A consequence of annotating
lineages with this rule is that the point of specification can be
identified by the transition from black to color (Figure 1D). This
point correlates well with the time when sibling cell fates become
statistically nonrandom (asterisk in Figure 1D).
In Figure 1D, Cell 1 is annotated as a specified oligodendroglial
progenitor since it produces four generations of cells which, be-
side two early deaths, are all identified as oligodendrocytes.
Cells 2 and 3 each produce three cell types, and cell 4 produces
two terminal cell types within three generations. This typical ex-
ample of four cells from one experiment demonstrates the high
degree of heterogeneity in CNS stem cell cultures. The emer-
gence of specified (colored) cells and their positions are de-
picted in Figure 1E. The time-lapse representation in Movie S2
shows again the spatial and temporal appearance of specified
cells. The control group contains lineages from 35 founders
that produced 897 terminal cells. The fate distribution was
34% neurons, 28% astrocytes, and 19% oligodendrocytes.
Five percent did not express detectable levels of lineage specific
antigens, 6% were lost, and 8% died.
If cells are classified as unspecified or specified, three discrete
temporal phases of cell division emerge (Figure S4A). At early
times, unspecified cells divide to produce more unspecified
cells. Later, divisions occur where one daughter is specified
and the other is not. Subsequently, the culture is dominated by
the expansion of specified cells. By plotting the cumulative num-
ber of cells of each fate through generations, the onset of spec-
ification of the neuronal, astroglial, and oligodendroglial lineages
is seen to be early and synchronous (Figure S4B). Note that the
cells were maintained in the presence of bFGF up to generation
four, demonstrating that specification to the unipotent state oc-
curs while cells are dividing in the presence of mitogen. Day 2 in
Figure S4C is equivalent to generation 4 in Figure S4B. Fatell Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier Inc. 671
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Fate Specification in Neural Stem Cell LineagesFigure 1. Lineage Analysis of a Time-Lapse Recording from a Single Area Demonstrates Early Fate Specification in Neural Lineages
(A) Time-lapse images of expanding and differentiating rat neural progenitors. D0–D7 reflect days after first image. Numbers in D0 refer to cells in (B) and (D).
Dotted outline in D4 represents the border of the permissive growth area. Scale bar, 100 mm. Still images are taken from Movie S1. Immunofluorescence shows
neurons in red (TUJ1), astrocytes in green (GFAP), and oligodendrocytes in blue (CNPase).
(B) Lineage dendrogram of time-lapse data. Media changes are indicated on the left (N2, DMEM/F12 with N2 supplement; bFGF, basic fibroblast growth
factor; NB, NeuroBasal; NT3, Neurotrophin 3; BDNF, brain-derived neurotrophic factor). Colored circles represent final fates corresponding to the colors
in (A).
(C) Schematic diagram of rules used to transform lineage dendrograms with final fates into lineage fate maps showing early points of specification.672 Cell Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier Inc.
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press fate-specific epitopes only after several days of differenti-
ation (day 5 for neurons and day 6 for astrocytes and oligoden-
drocytes, Figure S4C). Thus, the time of specification precedes
the appearance of fate-specific epitopes by 2 to 3 days.
A Rapid Potency Change in Proliferating Cells
To assess the potency of unspecified cells, each was assigned
a potency reflecting the terminal descendants it generates (Fig-
ure 2A). This representation is shown in Figure 2A for the same
lineage as in Figure 1. A summary of all this control data demon-
strates that at the beginning of imaging, 57% of the cells are tri-
potent (black diamonds), 31% are bipotent (open circles), and
11% are already unipotent (open triangles; Figure 2B). Within
three generations, the proportion of tripotent cells falls to less
than 10%. These data show, in a statistically robust manner,
that rapid loss of tripotency is concurrent with a transient increase
in the bipotent population. Later, a stable increase in the unipo-
tent population dominates. Withdrawal of the mitogen bFGF is
thought to induce fate choice (Cattaneo and McKay, 1990). How-
ever, at this point (generation 4), 80% of the cells are already
specified into a single fate. These data demonstrate that cell-
fate specification occurs in dividing cells in the presence of bFGF.
Toconfirmtheconclusion thatculturedCNSstemcellsarespec-
ified in the presence of bFGF, we cultured cells in the presence of
bFGF for an additional 2 days. We achieved the additional days of
culture by reducing cell density through random laser ablation at
the normal time of bFGF withdrawal (Figure 2C; Figure S5; Supple-
mental Experimental Procedures). According to control lineage
data at the time of bFGF withdrawal (control generation 3), the pop-
ulation is estimated to have 6% tripotent cells, 49% bipotent cells,
and 42% unipotent cells. Lineages for 43 founder cells after abla-
tion show that the surviving cells were 5% tripotent, 44% bipotent,
and 51% unipotent at the first time point (Figure 2C). The potency
distribution immediately after ablation almost perfectly overlaps
with the potencydistribution at the relevantpoint in thecontrolpop-
ulation in Figure 2B, despite continued cell division in the ablation
experiment in the presence of bFGF. These data demonstrate
that cells are specified with the same kinetics whether cultured
for 2 1/2 days or 4 1/2 days in the presence of bFGF.
The apparent potency of a cell is related to the number of prog-
eny produced by the cell; a true tripotent cell that divides only
once to produce two specified cells would, at most, appear as
a bipotent cell. If apparent bipotent cells were given the opportu-
nity to make additional cell divisions in the presence of bFGF,
their actual potency might be revealed. The laser ablation results
demonstrate that apparent potency is not a consequence of lim-
ited cell divisions and that cell-fate specification occurs in the
presence of bFGF.
Resetting Potency
Previous work from our lab demonstrated that most neural
progenitors remain multipotent through passage (Johe et al.,
1996). Lineages established after the third passage show that
after passage 3, 42% of the population is tripotent (Figure 2D).
Although the kinetics of fate restriction differ slightly in passageCe3 compared to passage 1, the two populations resemble one
another both in proportion and progression of fate restriction.
The frequency of tripotent cells is less than 2% after four gen-
erations in the presence of bFGF (Figure 2B). As cells are nor-
mally passaged every 2 to 3 days (equivalent to 4–6 generations),
the size of the tripotent population is expected to be near zero at
this time. The high frequency of tripotent cells at passage 3
(Figure 2D) could be a consequence of selection for multipotent
rather than specified cells through passage. To determine the
feasibility of the selection hypothesis, we calculated passage
efficiency by directly counting cells before, during, and 2 hr after
passage from passage 1 through passage 3. The plating effi-
ciency at each passage is 0.8. If there was strong selection
in favor of the tripotent cell at passage, then the maximum
proportion of tripotent cells after the third passage would be
2%3 1/0.8 = 2.5%. After passage three, the tripotent population
is 42%, showing that selection at passage cannot explain the
persistence of the multipotent state through time. These data
suggest that passage resets cells to a more primitive state.
Nonrandom Exit from the Tripotent State
To more precisely define changes as multipotent cells become
specified, we measured the types of transitions between parent
cells and their progeny. Using results from 20 tripotent founder
cells and eight bipotent founder cells, we tabulated the number
of events generating new tripotent, bipotent, and unipotent cells
at each generation in 50 tripotent cells, 174 bipotent cells, and
244 unipotent cells represented across seven generations
(Figure 2E). Self-renewal of a tripotent cell is common early but di-
minishes rapidly through generation. After the first division, the
most common product of a tripotent cell is a bipotent cell. Like-
wise, bipotent cells show a short phase of self renewal and rapidly
switch to the production of unipotent cells. This network of
changing states shows that tripotent cells almost always become
specified through bipotent intermediates. Statistical analysis of
observed and expected numbers of tripotent, bipotent, and uni-
potent cells supports the nonrandom transition from tripotent to
bipotent and bipotent to unipotent cell types (Figure S6).
The expression of CD15 has been proposed as a tool for pro-
spective isolation of stem cells from the adult and fetal brain
(Capela and Temple, 2002, 2006). CD15 is coexpressed with
CD133, and both epitopes have been used to perform fluores-
cence-activated cell sorting (FACS) isolation of multipotent neural
progenitors (Capela and Temple, 2002, 2006; Panchision et al.,
2007; Uchida et al., 2000). We found a weak correlation between
CD15 expressionand lossof potency at the population level; how-
ever, no correlation was seen between CD15 expression and
founder cell potency or the number of progeny derived from indi-
vidual cells (Supplemental Data and Figure S7). The lack of corre-
lation between early CD15 expression and potency or proliferative
capacity in single lineages prompts cautious interpretation of the
expression of surface epitopes without a precise lineage analysis.
CNTF and Astrocytic Fate Choice
To determine when fate choice can be modified by exogenous
signals, cells were exposed to CNTF. This ligand has been widely(D) Transformation of (B) using rules in (C). Asterisk indicates the calculated average time of nonrandomness for this lineage. (E) Ball representation of cell
position and cell fate from (A). Still images are taken from Movie S2.ll Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier Inc. 673
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Fate Specification in Neural Stem Cell LineagesFigure 2. Multipotency Is Rapidly Lost in the Presence of bFGF but Is Regained by Passage
(A) Each pie chart represents an individual cell from the lineage in Figure 1. Color distribution inside each cell represents its final fate distribution. Lost and dead
cells are excluded from the image for clarity. Siblings of lost or dead cells are indicated by a straight vertical line such as in the leftmost lineage in Cell 1.
(B–D) Percentage of new cells produced at each generation. Tripotent, black diamonds; bipotent, open circles; specified, open triangles. Boxes above indicate
the experimental design. (B) First passage (n = 35 founder cells). Arrow denotes the point of laser ablation for the culture in (C). (C) Fate distribution after laser
ablation at generation 3, first passage. Note the similar cell-class distribution between the first time point after ablation and the third generation in (B), (n = 43
founder cells). (D) Resetting of cell-fate potency after passage 3. Fate distribution of new cells produced at each generation after the third passage (n = 33 founder
cells).
(E) Total numbers of tripotent and bipotent founders and their descendants from all control experiments are represented as circles, where the dimensions are
proportional to their true abundance at each generation (generations shown on the x axis and potency shown on the y axis). Transitions in potency from parent
to daughter are represented by arrows. The width of each arrow represents the number of each type of transition measured in the lineage. The number reflects the
exact number of each transition across each generation.
The error bars in (B), (C), and (D) reflect the mean percentage ± SEM.used to study astrocytic fate choice and differentiation (Barnabe-
Heider et al., 2005; Bonni et al., 1997; Johe et al., 1996; Rajan
and McKay, 1998; Song and Ghosh, 2004). Figure 3A outlines674 Cell Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier Incthe experimental design for CNTF treatment. To determine the
change in plasticity through time, control media was supple-
mented continuously with CNTF either 3 hr before (CNTF3;.
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Fate Specification in Neural Stem Cell LineagesFigure 3. CNTFBiasesMultipotent Neural Progenitors toward the Astrocytic Fate through Early Instruction and Late Expansion of Astrocytic
Progenitors
(A) Experimental design of CNTF treatment.
(B) Immunofluorescent image of last frame of movie in Movie S3. Neurons are shown in red (TUJ1), astrocytes in green (GFAP), and nuclei are stained with DAPI.
(C) Lineage fate map of Movie S3. Note the late astrocytic divisions in (C).32 founder cells) or 24 hr after initiating imaging (CNTF+24;
43 founder cells). Exposure to CNTF promotes the production
of astrocytes that express high levels of glial fibrillary acidic pro-
tein (GFAP) (Figure 3B). This endpoint image demonstrates that
the field is dominated by GFAP-positive astrocytes but also con-
tains several neurons. Figure 3C shows a representative lineage
of rat CNS stem cells treated continuously with CNTF. The most
striking change in the CNTF-treated lineage is seen in the late ex-
pansion of specified astrocytes (compare Figures 3C and 1D).
To quantify the response of different cell populations to CNTF,
wecalculated the numberof tripotentand typeof bipotent anduni-
potent cells at each generation with and without CNTF treatment.
All values shown were normalized to the 35 founder cells lineaged
in thecontrolpopulation. CNTF treatment increased the numberof
dying progenitors (Figure 4A). In control cultures, every neuron
and astrocyte was unambiguously classified by marker expres-
sion and morphology. In CNTF+24 cultures, low numbers of cells
coexpressed both astrocytic and neuronal markers with an am-
biguous morphology. In CNTF3 treated cells, there was a signifi-
cant increase in the number of double-stained cells accounting for
3% of the total cells from CNTF3 lineages (Figure 4B). This new
cell population was scored as a separate fate.
Lineage analysis showed that the tripotent population was
slightly reduced in CNTF+24 and significantly reduced in CNTF3Celineages (Figure 4C). This might be expected from the larger
number of tripotent cells available to respond at 3 hr. Notice
that a significant difference from the control occurs in the
CNTF+24 lineage only after generation 3, consistent with the later
addition of CNTF. These data show that CNTF treatment clearly
reduces the number of tripotent cells (Figure 4C). The number of
NA and AO cells was also reduced, but there was a lesser effect
on the NO populations (Figures 4D, 4E, and 4F). The analysis of
unipotent cell types shows reduced numbers of neurons and
oligodendrocytes (Figures 4G and 4H). In contrast, the produc-
tion of astrocytes was enhanced (Figure 4I).
One explanation for the reduced NAO, NA, and AO popula-
tions and increase in the astrocytic population would be that tri-
potent cells are directly specified as astrocytes, bypassing the
normal bipotent intermediates. Increased astrocytic output
from NA and AO cells might provide an alternative explanation
for increased astrocyte numbers. To resolve these possibilities,
a database was constructed that reports every transition from
tri-, bi-, and unipotent parent to tri-, bi-, and unipotent daughter
cell at each generation. These data were used to define the fre-
quency of each possible cell-fate transition. The number of tran-
sitions from one generation to the next is plotted and, as we are
comparing different experiments, the data were normalized to
the number of cells in the control. The CNTF+24 and CNTF3ll Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier Inc. 675
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Fate Specification in Neural Stem Cell Lineagestreatments reduce the number of transitions from NAO to NA and
AO (the bipotent cells that give rise to astrocytes) (Figures 5A and
5B). In contrast, the transition from NAO parent to NO daughter
was unaffected by either CNTF treatment (Figure 5C). The pro-
duction of astrocytes from NA and AO cells was reduced by
CNTF treatment (Figure 5D). Therefore, the increased numbers
of astrocytes must be caused by events that occur prior to es-
tablishing the bipotent state.
The same analysis demonstrates that NAO to A transitions are
significantly increased by CNTF treatment (Figure 5E). The late
proliferative effect of CNTF contributes most of the increased
numbers of astrocytes seen at the end of the differentiation pe-
riod (Figure 5F). These data summarized in Figure 5G show
that the increase in astrocytes induced by CNTF is caused by
two distinct cellular mechanisms: an early instructive and a later
selective effect.
The early positive proastrocytic effect on tripotent NAO cells is
a remarkable feature of these data. The probability of transitions
from the NAO to bipotent states was modified in an interesting
way by CNTF treatment. The number of NO progeny was unaf-
fected, but fewer NA and AO cells were generated when in-
creased numbers of A cells were produced. In the CNTF-treated
condition, the probability that bipotent cells produce astrocytes
was also altered. Surprisingly, the probability of astrocyte pro-
duction from bipotent cells was reduced. These data show that
CNTF exerts both positive and negative instructive effects on as-
trocytic fates. There is a strong positive effect on the tripotent,
and a negative effect on bipotent, cells.
Induction of GFAP Expression
The assignment of fate in time-lapse lineage dendrograms is
based upon terminal immunoreactivity and retrospective analy-
sis. A specific intermediate filament protein, glial fibrillary acidic
protein (GFAP), is expressed in astrocytes and in precursor cells
in the adult brain (Doetsch et al., 1999). Two approaches were
used to relate the lineage data to this widely used molecular
Figure 4. Population Dynamics during
CNTF Treatment Reveals Sensitive Target
Cells and Sensitive Target Periods
(A–I) Cell counts of discrete cell types in each gen-
eration normalized to the total founding number of
cells in the control. CNTF added 3 hr before (3) or
24 hr after (+24) imaging. (A) Cumulative number of
dying and (B) mixed cells. (C) Normalized number
of tripotent cells in each generation. (D–F) Cumula-
tive number of bipotent cells; (G–I) Cumulative
number of unipotent cells; variance is calculated
as standard error for a binomial distribution.
Arrowheads above (A), (B), and (C) indicate the
time of CNTF addition. N, neuron; A, astrocyte;
O, oligodendrocyte; NAO, Tripotent; NA, NO, and
AO, bipotent; D death; M, mixed.
marker of the astrocytic state. First, we
measured the induction of GFAP expres-
sion by CNTF at shorter times to increase
confidence in the retrospective fate as-
signment. Second, a regulatory element
from the GFAP gene was used to measure promoter activity in
real time in all cells throughout a lineage analysis.
GFAP expression was assessed in cell populations fixed
each day after continuous CNTF treatment (Figure S8A). GFAP
expression is detected rapidly in the CNTF+24 condition, and
complete lineages were generated for the 36 hr following CNTF
treatment (Figure S8B). Astrocytic fate was assigned to GFAP-
expressing cells, but other fates were not assessed due to lack
of antigen expression at this early time point. As seen in the pre-
vious long-term studies, GFAP-expressing cells tend to have
sisters that also express GFAP. Retrospective analysis reveals
that the number of specified astrocytic progenitor cells is nearly
identical in the 36 hr and 8 day experiments (Figure S8C). The
short-term analysis of GFAP expression supports our previous
conclusion of early fate specification.
Fluorescence from a GFAP-GFP reporter in individual living cells
was used to examine early fate specification more precisely in the
astrocytic lineage. Neural stem cells were infected with a lentivirus
encoding the mouse GFAP promoter driving GFP. The viral trans-
gene provides robust GFP signal only in cells that also express the
endogenous GFAP protein (Figure S9). Due to a destabilizing se-
quence in the GFP reporter, it is possible to measure the short-
term activity of the promoter. To assess the dynamic activity of
this reporter at different phases of lineage development, we took
advantage of the continuous perfusion and easy access built into
the chamber design. These features allowed pulse-chase experi-
ments with brief exposure to CNTF at 0.5 days, 1.8 days, and
3.5 days during time-lapse imaging. The pulse was followed by a
chase where the mediumin the chamber was completelychanged.
These times were chosen to probe early, middle, and late phases
of lineage specification. Fluorescence images to measure GFP ex-
pressionwereacquiredevery 12hr for3days, thendaily for the bal-
ance of the experiment. These fluorescence images were inter-
leaved at the appropriate place in the DIC image stack (Movie S4).
This allowed the construction of fate maps where individual cells
were annotated with fluorescence signals throughout their lineage.676 Cell Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier Inc.
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specification occurred on average on day 1.3 (±0.6, n = 32;
marked by black arrow in Figure 6A). The lineage dendrogram
and associated micrographs shown in Figure 6A demonstrate
that the change in fluorescence through time in specified astro-
cytes and other fates is clearly different by day 3.5. At day 2.5,
other fates can also express the reporter. However, this weak ex-
pression is only transient and contrasts with the continued in-
crease in promoter activity seen in specified astrocytes. In the
quantitative summary of changes in promoter activity through
time, a clear increase in signal is first seen on day 2.5 (Figure 6B).
At this time, transcriptional activation of the reporter occurred in
both astrocytic and nonastrocytic cells but was only sustained in
specified astrocytes. These results unambiguously validate the
early differences between lineages predicted by the long-term
retrospective analysis. The difference between the time when
astrocytic fates are seen using lineage analysis and GFAP ex-
pression points to the importance of further studies on the early
events that generate distinct cell fates.
DISCUSSION
Stem cells are defined by the ability to self renew and give rise to
specified cell types. In vitro cultures of neural stem cells can
Figure 5. CNTF Biases Normal Parent to
Daughter Transitions in Potency toward
Precocious Production of Astrocytes
(A–C) Tripotent parent to bipotent daughter transi-
tions.
(D–F) All sources of astrocytes. (D) Bipotent parent
directly to astrocytic daughter (E) Tripotent parent
directly to astrocytic daughter. (F) Specified astro-
cytic progenitor to astrocyte. Transition 1 occurs
between generation 1 and 2. (G) Schematic model
of CNTF action on CNS stem cell cultures. CNTF
promotes astrogliogenesis by direct specification
of tripotent cells into the astrocytic fate and later
selective expansion of specified astrocytes. Dot-
ted lines and reduced font size indicate fewer
events. Variance is calculated as standard error
for a binomial distribution.
recapitulate the expansion, specification,
and maturation of each of the major cell
types in the mammalian CNS. For most
therapeutic applications, cells must be
expanded in vitro before grafting. Thus,
the detailed characterization of cultured
CNS stem cells merits attention from the
research community as well as the cell-
based therapeutic community. The limi-
tation of in vitro analysis is that results
achieved in vitro cannot be directly ex-
trapolated to the environment in vivo.
For long-term lineage analysis, the only
reasonably tractable system is a dissoci-
ated culture system such as the one em-
ployed here. We focused our studies on
the E14.5 rat cerebral cortex because
this particular developmental stage and brain region provides
reproducible access to the neuronal, astrocytic, and oligoden-
droglial fates. One might expect that cells from earlier develop-
mental stages would consist of a more substantial multipotent
self-renewing population and older cells would be more
specified.
Cell type is typically defined by morphology, behavior, or the
expression of specific epitopes, yet these are often far down-
stream from the decision points in cell-fate specification. We de-
fine the point of cell-type specification as the mitosis that pro-
duces only one cell type. Significant evidence supports the
asymmetric localization of cell-fate determinants prior to mitosis
(Chenn and McConnell, 1995; Lu et al., 2000; Sun et al., 2005),
but mitosis is required to segregate discrete fates into daughter
cells. We, therefore, accept mitosis as the earliest point of cell-
fate specification and label lineage dendrograms using this ap-
proach. Our ablation study demonstrates that our determination
of potency in vitro is accurate and that the tripotent population
has almost disappeared by generation 3 to 4. These processes
all occur in mitotic populations in the presence of bFGF. There-
fore, there is no correlation between withdrawal from the cell-
cycle and cell-type specification. The rat cerebral cortex at
E14.5 is comprised largely of a mitotic population that does
not express epitopes of specified cells. Significant changes inCell Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier Inc. 677
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(Caviness et al., 1995; Fasano et al., 2007). It is possible that
the kinetics of fate specification we observe is a consequence
of the specific developmental stage or of the specific in vitro sys-
tem we used. However, it is also possible that the mitotic popu-
lations observed in vivo are actually proliferating specified cell
populations.
The opposition between self-renewal and differentiation
mechanisms in a single cell has been explained by symmetric
and asymmetric cell division (Morrison and Kimble, 2006; Noctor
et al., 2004). A reiterative asymmetric neurogenic program has
been identified in acutely isolated mouse neural stem cells be-
fore passage (Qian et al., 2000). In contrast, the goal of our
work was to understand the lineage mechanisms in cells that
are expanding. In our system, the stem cell state was not main-
tained by asymmetric self-renewal but through resetting of more
specified cells to a higher level of potency at passage (see
Figure 6. GFAP Reporter Expression in
Neural Stem Cell Lineages Validates Early
Astrocytic Fate Specification
(A) Lineage fate map from a single infected founder
cell. The vertical colored lines represent fate. The
colored ovals indicate GFP expression level at
each point of fluorescence imaging. The GFP
scale represents mean fluorescence, in arbitrary
units, as discrete colors. Example fluorescence
micrographs and corresponding DIC micrographs
demonstrate the background-subtracted signal
for each cell. Scale bar, 100 mm. Media conditions
and CNTF pulse chase are shown to the left (black
boxes represent the duration of CNTF pulse).
(B) DF/F at the indicated time points. The inset
magnifies the low values centered at day 2.5. Error
bars reflect SEM.
ablation discussion above). There is
significant interest in the mechanism of
reprogramming somatic cells to a pluripo-
tent state after viral transduction (Taka-
hashi and Yamanaka, 2006). It has also
been demonstrated that it is harder to
reprogram fully differentiated B cells in
the hematopoietic system (Hanna et al.,
2008). Resetting specified neural stem
cells to a higher state of potency is a ro-
bust and simple procedure that reveals
the plasticity of the specified state. The
fact that these cells are able to be reset
demonstrates that their fate was speci-
fied and not committed. This simple sys-
tem provides new tools in the investiga-
tion of the epigenetic mechanisms that
maintain and restrict stem cell potency.
Our analyses demonstrate that CNS
stem cells cultured from the midgestation
cortex are heterogeneous in develop-
mental potency. We examined the plas-
ticity of this heterogeneous population
using an exogenous ligand, CNTF.
CNTF acts instructively at early times to generate increased
numbers of astrocytes, bypassing the normal NA and AO bipo-
tent intermediates. At late times, astrocytic progenitors show in-
creased response to CNTF measured by changes in the activity
of the GFAP promoter and enhanced proliferation. The endoge-
nous GFAP gene expression and a GFAP-reporter construct
confirm that CNTF-responsive astrocyte progenitors can be
uniquely identified 2 days after fate specification (Figure 6). Con-
sidering GFAP is a downstream consequence of astrocytic fate
specification and GFP fluorescence requires expression and
maturation, we expect a delay in reporter expression after fate
specification. GFAP expression is thought to define multipotent
neural precursors in the adult brain (Doetsch et al., 1999). In vitro
experiments show that a combination of STAT3 and SMAD sig-
naling is required for GFAP induction in neural stem cells (Fukuda
et al., 2007; Nakashima et al., 1999). Complete lineage analysis
using GFAP_GFP now defines an early narrow time window for678 Cell Stem Cell 3, 670–680, December 4, 2008 ª2008 Elsevier Inc.
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tions. The lack of correlation between the stem cell state and
CD15 expression indicates that more robust markers of unspec-
ified cell types would be beneficial. Lineage analysis will play an
important role in identifying and validating such markers. Our
analysis demonstrated that instructive and selective mecha-
nisms can act on different elements of a single stem cell clone.
Further development of this approach will enable the identifica-
tion of relevant intermediates and define their specific contribu-
tions to the production of heterogeneous populations such as
tissues and organ systems.
EXPERIMENTAL PROCEDURES
Cell Culture
Embryonic day 14.5 embryos were extracted from pregnant Sprague-Daw-
ley rats according to the NINDS guidelines. Cerebral vesicles were isolated
without enzymatic digestion as previously described (Johe et al., 1996) and
plated at 20,000 cells/cm2 in poly-L-ornithine /fibronectin-coated 10 cm
tissue culture plates (1.0 3 106 cells) and grown for 4 days in DMEM/F12
(MediaTech) with N2 supplement using human apo-transferrin (Sigma), hu-
man bFGF (R&D Systems, 10 ng/ml), and insulin (Sigma, 25 ng/ml). bFGF
was added daily with complete media replacement every second day.
To passage cultures, cells were gently passaged in HBSS (GIBCO 14185-
042) with added HEPES (3.9 g/l) pH 7.1 and plated at 10,000 cells/cm2
onto 24.5 mm coverslips (1.0 size, Carolina Biological) coated as described
below.
Long-Term Imaging of Migratory Cells
Restricting cells to the field of view was accomplished by creating 300 mm rect-
angular islands of extracellular matrix with an etching device (Figure S3). Re-
stricted growth areas are created by coating sterile 25 mm round coverslips
(Assistent, Karl Hecht KG) with 500 mg/ml poly-L-ornithine (Sigma), then
Bovine fibronectin 10 mg/ml (R&D Systems) previously dialyzed against
1000 volumes of PBS. Fibronectin is indirectly visualized by fluorescence
from Alexa 555-conjugated fibronectin (Monoclonal Antibody Labeling Kit,
Invitrogen). Coverslips are seeded with CNS stem cells then etched to create
islands (see Figure S3 for diagrams and discussion).
Live-Cell Chamber
The system is composed of two chambers, (A) a novel gas-tight wet/dry cham-
ber that we designed to regulate media and gas composition (U.S. Patent num-
ber for live-cell chamber: 7,091,035) and (B) a custom opaque light-tight outer
chamber that allows precise temperature regulation (Precision Plastics, Belts-
ville, MD). Using the gas-tight chamber, we maintained a 5% CO2, 5% O2
environment and performed complete media changes while continuously
imaging. Temperature was regulated (37C ± 0.1C) using an AirTherm (WPI).
Between media changes, media was perfused at a rate of 30 ml per hour using
25 ml gas-tight syringes (Hamilton) and a syringe pump (Harvard Apparatus).
Stainless steel tubes connect the syringe to the growth chamber (see
Figure S2 for arrangement).
Imaging
Cells were imaged using a Zeiss Axiovert 135TV microscope with a 403,
1.3 NA oil-immersion objective. DIC images from single restricted growth
areas were captured with an Orca ER (Hamamatsu) CCD camera every
2 min. To image multiple areas from one experiment, we used a computer-
controlled motorized stage (Ludl Mac5000) with a linear encoder. Metamorph
software (Universal Imaging) was used to control all components. To minimize
phototoxicity, 15 ms exposure times were achieved using a shutter (UniBlitz).
Immunostaining
Cells were fixed with 4% paraformaldehyde and then stained for lineage-
specific antigens without removing the live-cell chamber from the microscope
stage. Cells were blocked in 10% normal goat serum with 0.1% Triton X-100,
then labeled with mouse anti-CNPase IgG1 (Chemicon), mouse anti-BIII-Cetubulin IgG2A (TUJ1, R&D Systems), rabbit polyclonal anti-Glial Fibrillary Acidic
Protein (DAKO), and DAPI (Sigma). For surface staining with SSEA-1 (MC-480
from Developmental Studies Hybridoma Bank), Triton was omitted. Secondary
antibodies include Alexa 568-labeled goat anti-mouse IgG1 (Invitrogen), Alexa
488-labeled goat anti-mouse IgG2A (Invitrogen), and Cy5-labeled goat anti-
rabbit polyclonal (Jackson Immunoresearch). For live-cell staining with
CD15-FITC (Becton Dickinson), cells were incubated with antibody (8 mg/ml)
for 15 min without blocking and then washed three times with media before
fluorescent images were acquired. To quantify fluorescence in CD15-FITC
stained samples, we used ImageJ (NIH) to define regions of interest within
the soma of each cell. Reported values are average fluorescence minus aver-
age background from adjacent areas.
Lineage Analysis
Full-length recordings were assembled into stacks using Metamorph, AVIEdit,
and ImageJ. TIFF stacks of time-lapse data were stabilized using the ImageJ
plugin Image Stabilizer. Contrast was enhanced using the Shadow Illuminator
plugin (Intrigue Technologies) to Photoshop CS (Adobe). Lineages were
manually generated and annotated for terminal fates and mitosis times using
SIMIBioCell (Schnabel et al., 1997). Using Lineage Analyzer (Custom pro-
grammed by EYE Biomachines for this application) and Microsoft Excel, we
calculated cell-fate potency based upon cell output: tripotent cells produce
at least one neuron, one astrocyte, and one oligodendrocyte. Bipotent cells
produce two fates, and unipotent cells produce only one. Lost, dying, and un-
stained cells were excluded from summary calculations. The rationale for ex-
cluding dead and lost cells (each contributing 6% and 8%, respectively, of
total terminal fates) is that most lost and dying cells are found in late genera-
tions after cell-type specification has already been established. Therefore, it
is likely that dying cells and surviving siblings would share the same fate,
and therefore, not alter parent cell fates. The rationale for excluding unstained
cells (5% of total) is that a large proportion of these unstained cells appear like
young specified progenitors that have simply not expressed terminal markers.
These cells, when stained with anti-nestin antibodies, are nonreactive (data
not shown), suggesting that they are not persistent stem cells.
Lentiviral GFAP_GFP Reporter Analysis
Lentivirus encoding the 1.7 Kb mouse GFAP promoter and copGFP was
purchased from System Biosciences Inc. A multiplicity of 16 particles per
cell resulted in a productive infection in roughly half the cells. Unlike other
experiments, here we used rat neural stem cells that were frozen at the first
passage. Frozen cells were plated and infected with virus immediately in
N2 + bFGF for 12 hr. Forty-eight hours later, cells were passaged onto glass
coverslips for long-term culture and imaging. Epifluorescence images were
captured each 12 hr until day 3½ and then daily afterward using the same
acquisition parameters—100 ms exposure with a neutral density filter that
reduces the exposure of cells to fluorescent light by a factor of 100 (Sutter
Lambda LS 300W Light Source). Complete lineage analysis was performed
on assembled image stacks. The fluorescent signal from each cell was mea-
sured after background subtraction and manual annotation of regions of inter-
est using ImageJ. The fluorescence signal from the first founding specified cell
in each lineage (F) was used as a point of normalization to all derivative cells in
the lineage. To calculateDF/F, F was subtracted from the signal from each cell,
then divided by F. Using this approach, the change in signal through time in
different cell types is readily apparent.
SUPPLEMENTAL DATA
The Supplemental Data include ten figures, one table, Supplemental Experi-
mental Procedures, and four movies and can be found with this article online
at http://www.molecule.org/supplemental/S1934-5909(08)00482-7.
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